Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Potential future targets for treating ocular neovascularization.

Fina C Barouch1, Joan W Miller

  • 1Department of Ophthalmology, Harvard Medical School, Massachusetts Eye and Ear Infirmary, 243 Charles Street, Boston, MA 02114, USA.

Ophthalmology Clinics of North America
|August 29, 2006
PubMed
Summary

Mediators drive ocular neovascularization (NV). Targeting these mediators, alongside inflammation and apoptosis, offers potential treatments for ocular NV, possibly through combined therapeutic approaches.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reference map of multimodal vision deficits in intermediate age-related macular degeneration: contrast sensitivity and low-contrast visual acuity.

The British journal of ophthalmology·2026
Same author

Systemic Statin Use and Reduced Risk of Repeat Retinal Detachment Repair: A Retrospective Cohort Study.

Ophthalmology. Retina·2026
Same author

Intravitreal Anti-VEGF Injection Transitions Across Bevacizumab, Biosimilar, and Branded Medications: The IRIS Registry Study.

Journal of vitreoretinal diseases·2026
Same author

Cataract Surgery and the Risk of Conversion from Dry to Neovascular Age-related Macular Degeneration in the IRIS© Registry.

Ophthalmology·2026
Same author

Recent vaccination exposure and central serous chorioretinopathy.

Eye (London, England)·2026
Same author

Neuroprotective Agents for Photoreceptor Rescue Following Experimental Retinal Detachment in Rodents: A Systematic Review.

Investigative ophthalmology & visual science·2026

Area of Science:

  • Ophthalmology
  • Vascular Biology
  • Pharmacology

Background:

  • Ocular neovascularization (NV) is a significant cause of vision loss.
  • Multiple signaling pathways and cellular processes contribute to ocular NV development.

Purpose of the Study:

  • To review potential therapeutic targets for ocular NV.
  • To explore the role of angiogenesis, inflammation, and apoptosis in ocular NV.
  • To discuss the potential of combination therapies for ocular NV.

Main Methods:

  • Literature review of preclinical and clinical studies.
  • Analysis of mediators involved in ocular NV.
  • Evaluation of therapeutic strategies targeting angiogenesis, inflammation, and apoptosis.

Related Experiment Videos

Main Results:

  • Numerous mediators identified as potential targets for ocular NV treatment.
  • Several targets have shown promise in preclinical models and are under clinical investigation.
  • Non-angiogenic pathways like inflammation and apoptosis are also relevant therapeutic avenues.

Conclusions:

  • Targeting various mediators, including those involved in angiogenesis, inflammation, and apoptosis, is crucial for effective ocular NV treatment.
  • Combined therapeutic strategies may offer synergistic benefits for managing ocular NV.